BlackRock Health Sciences Trust II (BMEZ)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in BlackRock Health Sciences Trust II, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

BlackRock Health Sciences Trust II (BMEZ) has returned -2.43% so far this year and 8.12% over the past 12 months.

Based on dividend-adjusted daily data since Jan 29, 2020, BMEZ's average daily return is +0.03%, while the average monthly return is +0.47%. At this rate, your investment would double in approximately 12.3 years.

Historically, 52% of months were positive and 48% were negative. The best month was Nov 2020 with a return of +17.4%, while the worst month was Jan 2022 at -14.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, BMEZ closed higher 51% of trading days. The best single day was Mar 24, 2020 with a return of +14.5%, while the worst single day was Mar 16, 2020 at -17.0%.

BlackRock Health Sciences Trust II has an annualized alpha of -2.60%, beta of 0.70, and R² of 0.35 versus S&P 500 Index. Calculated based on daily prices since January 30, 2020.

• This stock participated in 112.52% of S&P 500 Index downside but only 82.89% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.70 may look defensive, but with R² of 0.35 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.35 means the benchmark explains less than half of this stock's behavior — treat beta with caution or consider switching to a more representative benchmark.

BMEZ ranks 54 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for BlackRock Health Sciences Trust II (BMEZ) and compare them to a chosen benchmark (S&P 500 Index).

BlackRock Health Sciences Trust II provided a 11.62% dividend yield over the last twelve months, with an annual payout of $1.67 per share. The company has been increasing its dividends for 2 consecutive years.

The table displays the monthly dividend distributions for BlackRock Health Sciences Trust II. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the BlackRock Health Sciences Trust II. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BlackRock Health Sciences Trust II was 46.19%, occurring on May 11, 2022. The portfolio has not yet recovered.

The current BlackRock Health Sciences Trust II drawdown is 21.72%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of BlackRock Health Sciences Trust II over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how BlackRock Health Sciences Trust II is priced in the market compared to other companies in the Capital Markets industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.